Oracle to buy drug safety firm Relsys.

(From vnunet)

Oracle has announced plans to acquire Relsys, a firm that provides drug safety and risk management solutions to the health sciences industry.

Terms of the deal have not been disclosed, but Oracle said that it will add Relsys to its Health Sciences global business unit.

The database vendor claimed in a report that the combination of expertise will deliver the "only suite of software applications that supports end-to-end drug safety processes across clinical development, post-market surveillance and …